NCT05420168

Brief Summary

This research focuses on the development and validation of indicators on the relevance of antibiotic prescriptions. The investigators want to propose transferable tools to other healthcare institutions to allow automated construction of quality indicators as part of a structured approach to improve future practices. The main objective of the study is to develop indicators on the appropriateness of antibiotic prescriptions and on surgical prophylaxis automated from the hospital information system and to assess their criterion validity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,115

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

8 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 15, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 15, 2022

Status Verified

April 1, 2022

Enrollment Period

4 years

First QC Date

May 24, 2022

Last Update Submit

June 14, 2022

Conditions

Keywords

AntibioticRelevanceIndicatorsAntibioprophylaxis

Outcome Measures

Primary Outcomes (1)

  • Sensitivity of the automatic tool to identify inappropriate antibiotic prescriptions compared to classical practices audits (gold standard).

    Indicator "inappropriate treatment lasting more than 7 days": antibiotic treatment initiated or continued more than 7 days in clinical situations (urinary and respiratory infections) where a shorter treatment is recommended Indicator "surgical antibiotic prophylaxis lasting more than 24 hours": antibiotic given for a more than 24 hours for a surgical procedure requiring antibiotic prophylaxis The gold standard is the judgement of prescription appropriateness by infectious diseases experts. The gold standard will be measured independently from the automatic tool. Data will be manually extracted from patient electronic health record and assessed, independently, by two infectious diseases specialists to identify inappropriate prescriptions. In case of disagreement, an expert committee will be convened.

    Between January 2021 and December 2024

Secondary Outcomes (8)

  • Metrological performances of each indicator

    Between January 2021 and December 2023

  • Number of responses done by the system

    Between December 2022 and December 2024

  • Number of response with justification of the prescription

    Between December 2022 and December 2024

  • Number of alerts without responses from the prescriber

    Between December 2022 and December 2024

  • Evaluate the score with scale MAUQ_E

    Between June 2023 and December 2024

  • +3 more secondary outcomes

Study Arms (1)

Patient who received antibiotic prophylaxis

Patient who received antibiotic prophylaxis to assess appropriateness and consumption of treatment.

Other: Automatic tool to identify inappropriate antibiotic prescriptions

Interventions

The system will identify inappropriate antibiotic prescriptions.

Patient who received antibiotic prophylaxis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients whose medical and administrative data are available in an electronic format in the hospital information system, Adult patients aged over 18.

You may qualify if:

  • Patients whose medical and administrative data are available in an electronic format in the hospital information system
  • Adult patients aged over 18;
  • Patients hospitalized at the Bordeaux University Hospital or one of the hospital of the territorial organization ;
  • Patients hospitalized between 01/01/2022 and 31/12/2024 ;
  • Indicator 1: "antibiotic treatments of more than 7 days without justifications"
  • Patients with of a hospitalization of more than 24 hours;
  • Patients with urinary or respiratory infections on admission or during the hospitalization (including sepsis related to urinary or respiratory infection);
  • Patients with a prescription for at least one antibiotic, initiated on admission or during the hospitalization, for more than 7 days including the hospital prescription AND the discharge prescription
  • Indicator 2: "surgical antibiotic prophylaxis lasting more than 24 hours"
  • Patients with surgery requiring an antibiotic prophylaxis
  • Patients having received antibiotic prophylaxis

You may not qualify if:

  • Patients not hospitalized at the Bordeaux University Hospital or one of the hospital of the territorial organization.
  • Patients whose medical and administrative data are not available in an electronic format in the hospital information system;
  • Patients who have refused the secondary use of their data for research purpose
  • Indicator 1: "Indicator of antibiotic treatments of more than 7 days without justifications"
  • Patients with another concomitant infectious pathology
  • Patient with pulmonary or urinary tuberculosis
  • Indicator 2: "surgical antibiotic prophylaxis lasting more than 24 hours"
  • Patients without any surgery or with surgery for which antibiotic prophylaxis is not required
  • Patients without antibiotic prophylaxis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Arcachon Hospital

Arcachon, 33120, France

NOT YET RECRUITING

Blaye Hospital

Blaye, 33390, France

NOT YET RECRUITING

Bordeaux University Hospital

Bordeaux, 33000, France

RECRUITING

Charles Perrens Hospital

Bordeaux, 33000, France

NOT YET RECRUITING

Cadillac Hospital

Cadillac, 33410, France

NOT YET RECRUITING

Sud-Gironde Hospital

Langon, 33210, France

NOT YET RECRUITING

Libourne Hospital

Libourne, France

NOT YET RECRUITING

Sainte Foy la Grande Hospital

Sainte-Foy-la-Grande, 33220, France

NOT YET RECRUITING

Study Officials

  • Frantz THIESSARD, MD, PhD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2022

First Posted

June 15, 2022

Study Start

January 2, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 15, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations